Huntingtin phosphorylation and signaling pathways that regulate toxicity in Huntington's disease

被引:8
|
作者
Humbert, S [1 ]
Saudou, F [1 ]
机构
[1] Ctr Univ Orsay, Inst Curie, CNRS, UMR 146, F-91405 Orsay, France
关键词
signal transduction; MAP kinase; IGF-1; PKB/Akt; phosphorylation; polyglutamine disorders;
D O I
10.1016/S1566-2772(03)00057-4
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Despite an intensive research on the protein huntingtin that causes Huntington's disease, little is known about the dystregulation of signal transduction pathways and their role in the pathological process. PolyQ expansion in huntingtin causes the activation of various pathways that may participate in cell death. Of particular interest is the role of the mitogen activated protein kinases. In addition, modification of huntingtin by phosphorylation might also play an important role in the disease by modulating the toxicity of mutant polyQ-huntingtin. For instance. phosphorylation of polyQ-huntingtin at serine 421 is induced by the pro-survival pathway insulin growth factor 1/Akt leading to a decreased polyQ-huntingtin-induced cell death. Studying such neuronal survival and death pathways and their components in HD will certainly lead to a better knowledge of huntingtin function/dysfunction in disease. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:149 / 155
页数:7
相关论文
共 50 条
  • [21] Huntington's disease: Huntingtin and the control of axonal transport
    Zala, D.
    Liot, G.
    Humbert, S.
    Saudou, F.
    JOURNAL OF NEUROCHEMISTRY, 2009, 110 : 60 - 60
  • [22] Huntingtin Lowering Strategies for Disease Modification in Huntington's Disease
    Tabrizi, Sarah J.
    Ghosh, Rhia
    Leavitt, Blair R.
    NEURON, 2019, 101 (05) : 801 - 819
  • [23] Targeting Huntingtin in Patients with Huntington's Disease Reply
    Tabrizi, Sarah J.
    Smith, Anne V.
    Bennett, C. Frank
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (12): : 1181 - 1182
  • [24] Role of wild type huntingtin in Huntington's disease
    Cattaneo, E
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2005, 76
  • [25] SUMO modification of Huntingtin and Huntington's disease pathology
    Steffan, JS
    Agrawal, N
    Pallos, J
    Rockabrand, E
    Trotman, LC
    Slepko, N
    Illes, K
    Lukacsovich, T
    Zhu, YZ
    Cattaneo, E
    Pandolfi, PP
    Thompson, LM
    Marsh, JL
    SCIENCE, 2004, 304 (5667) : 100 - 104
  • [26] Targeting Huntingtin Expression in Patients with Huntington's Disease
    Tabrizi, Sarah J.
    Leavitt, Blair R.
    Landwehrmeyer, G. Bernhard
    Wild, Edward J.
    Saft, Carsten
    Barker, Roger A.
    Blair, Nick F.
    Craufurd, David
    Priller, Josef
    Rickards, Hugh
    Rosser, Anne
    Kordasiewicz, Holly B.
    Czech, Christian
    Swayze, Eric E.
    Norris, Daniel A.
    Baumann, Tiffany
    Gerlach, Irene
    Schobel, Scott A.
    Paz, Erika
    Smith, Anne V.
    Bennett, C. Frank
    Lane, Roger M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (24): : 2307 - 2316
  • [27] The IGF-1/Akt pathway is neuroprotective in Huntington's disease and involves huntingtin phosphorylation by Akt
    Humbert, S
    Bryson, EA
    Cordelières, FP
    Connors, NC
    Datta, SR
    Finkbeiner, S
    Greenberg, ME
    Saudou, F
    DEVELOPMENTAL CELL, 2002, 2 (06) : 831 - 837
  • [28] QUANTIFYING MUTANT HUNTINGTIN IN HUNTINGTON'S DISEASE CSF
    Wild, Edward
    Robertson, Nicola
    Miller, James
    Traeger, Ulrike
    Haider, Salman
    Macdonald, Douglas
    Langbehn, Douglas
    Kuhn, Rainer
    Weiss, Andreas
    Tabrizi, Sarah
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2014, 85 (10):
  • [29] Huntingtin Aggregates in the Olfactory Bulb in Huntington's Disease
    Highet, Blake
    Dieriks, Birger Victor
    Murray, Helen C.
    Faull, Richard L. M.
    Curtis, Maurice A.
    FRONTIERS IN AGING NEUROSCIENCE, 2020, 12
  • [30] Huntington's disease: degradation of mutant huntingtin by autophagy
    Sarkar, Sovan
    Rubinsztein, David C.
    FEBS JOURNAL, 2008, 275 (17) : 4263 - 4270